AzTrials
AzTrials

Motor DisordersNCT06521918

Combined Artificial Intelligence and Mobile Application for Remote Infant Motor Screening: Development and Validation

An observational study of Motor Disorders, run by National Taiwan University Hospital at 1 site in Taiwan.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The purpose of this study is therefore five-fold: (1) designation of an APP "Baby Go" version 3.0 to include the assessment, follow-up, and education functions for parental use at home, (2) development and validation of the AI algorithm for infant motor assessment based on home videos obtained from term and preterm… Read more about this study

Who is it for?
Ages 2 to 18 monthsHealthy volunteers can take part
Conditions the study is for
Motor Disorders
How many people
242 participants
Where
1 siteTaiwan
Study dates
17 Oct 2024to 31 Jul 2027
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 2 to 18 months
  • All sexes
  • Healthy volunteers accepted
  • Child

Study population: This study will recruit preterm and term infants from National Taiwan University Children's Hospital (NTUCH), Taipei, Taiwan, with the former recruited from the neonatal follow-up clinic and the latter from the well-baby follow-up clinic. Two pediatric physiotherapists providing early intervention to the participating infants will be invited to complete a feedback questionnaire about the APP "Baby Go."

The inclusion criterion is:

Preterm infants: gestational age < 37 weeks, birth body weight < 2,500 grams, and corrected age of 2-18 months.

Term infants: gestational age 37-42 weeks, birth body weight >2,500 grams, and age of 2-18 months.

Clinicians: who provide early intervention to the participating infants in this study.

The exclusion criterion is:

Infants: parents can not read Chinese. Clinicians: can not read Chinese

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Suh-Fang Jeng, Professor contact

886-2-33668132

jeng@ntu.edu.tw

Taiwan1 site, 1 recruiting
  • National Taiwan University

    Taipei, Taiwan, 100

    Suh-Fang Jeng, Professor, 886-2-33668132, jeng@ntu.edu.tw

    Recruiting

Other trials in Taiwan

About this study

The purpose of this study is therefore five-fold: (1) designation of an APP "Baby Go" version 3.0 to include the assessment, follow-up, and education functions for parental use at home, (2) development and validation of the AI algorithm for infant motor assessment based on home videos obtained from term and preterm infants, (3) comparison of parental perception and report with AI-driven assessment results, (4) examination of the predictive validity of the AI algorithm for infant motor assessment on subsequent outcome, and (5) investigation of the usability of the APP "Baby Go" version 3.0 in parents and clinicians.

Read the detailed description

Background and Purpose: Early identification and intervention of infants who are at risk of developmental disorders (such as preterm infants) is an important global health policy and action. The number of children with developmental disorders referred for early intervention in Taiwan has increased in the last ten years. Yet, they are more likely diagnosed and referred for intervention at an age beyond two years. Existing developmental diagnostic tests are frequently accessible at hospitals, whereas screening tests are often based on parental reports that are influenced by parents' knowledge and interpretation. Although the emerging artificial intelligence (AI) technology and deep learning have enabled the tracking and recognition of human movements in standardized laboratory settings, whether its incorporation with mobile application (APP) is feasible and accurate for infant motor assessment at home has rarely been investigated. Therefore, this study continues our previous endeavors that applied AI and machine learning to classify several infant movements at standardized laboratory. This study aims to combine the AI algorithm and machine learning with an APP for infant motor assessment in home setup. The specific purposes are (1) designation of an APP "Baby Go" version 3.0 to include the assessment, follow-up, and education functions for parental use at home, (2) development and validation of the AI algorithm for infant motor assessment based on home videos obtained from term and preterm infants, (3) comparison of parental perception and report with AI-driven assessment results, (4) examination of the predictive validity of the AI algorithm for infant motor assessment on subsequent outcome, and (5) investigation of the usability of the APP "Baby Go" version 3.0 in parents and clinicians. Method: This study will recruit 100 preterm infants, 20 term infants aged 2 to 18 months (corrected for prematurity), 120 infants' parents, and 2 clinicians at National Taiwan University Children's Hospital. The APP "Baby Go" version 3.0 will contain the features of age-based motor assessment with 2 to 5 movements at each age, follow-up, and education module. The parents will be asked to video record their baby's movements in prone, supine, sitting, and standing at home biweekly and to simultaneously upload the video files via the APP during the age period of 2 to 18 months, followed by recording their infant's age of walking attainment. Trained physiotherapists will annotate all video files and the results will serve as the gold standards for validation of the data of the AI model and parental perception. The video data will be randomly split into the training and testing set with an 8:2 ratio for model development and validation. The AI model of infant motor assessment will be examined for its predictive validity on age of walking attainment. The parents and clinicians will fill out the APP usability survey. Innovation and Significance: This study is an incremental AI model advancement in tracking and recognizing infant movements from a laboratory-based classification system to a home-based assessment system. The automatic AI-driven infant motor assessment via the APP "Baby Go" will provide parents and healthcare providers in Taiwan with innovative and feasible developmental resources in remote communities. The results are insightful to assist pediatricians and physiotherapists in planning diagnostic assessment and early intervention for infants at risk of neuromotor disorders.

Conditions
Motor Disorders
Keywords
AI, infant motor assessment, APP, validation
Medical subject headings
Motor Disorders, Alzheimer Disease

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT06521918
Study groupRoleWhat they receive
Term infantsThe inclusion criterion is: gestational age 37-42 weeks, birth body weight >2,500 grams, and age at 2-18 months. The exclusion criterion is: parents can not read Chinese.
Preterm infantsThe inclusion criterion is: gestational age < 37 weeks, birth body weight < 2,500 grams, and corrected age of 2-18 months. The exclusion criterion is: parents can not read Chinese.
CliniciansThe inclusion criterion is: who provide early intervention to the participating infants in this study. The exclusion criterion is: can not read Chinese

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Alberta Infant Motor Scale (AIMS)

    motor function in supine, prone, sitting and standing position

    Measured: 3 - 18 months of age

  2. Age of walking attainment

    Age of attaining independent walking for at least five steps

    Measured: 9 - 18 months of age

  3. User experience from parents

    Parents' perspectives on the use of the APP "Baby Go" were collected using Google Forms (For parents: https://forms.gle/BPL7CWopaB7qk3388). The questionnaire for parents was customized for the APP "Baby Go" in this study and adapted from a survey used in the "Baby Moves" APP previously described by Kwong et al. The questionnaire for the parents consisted of three sections: (1) frequency of the APP use, (2) benefits of the APP use, and (3) user's experience. Questionnaires contained three types of measures: (1) multiple choice, (2) five-point Likert scale, and (3) open-ended questions.

    Measured: When the infant approached 6 months, 12 months, and 18 months

  4. User experience from clinicians

    Clinicians' perspectives on the use of the APP "Baby Go" were collected using Google Forms (for clinicians: https://forms.gle/3L7nGKe2ZTT39t7n6). The questionnaire for clinicians is customized for the APP "Baby Go" in this study and adapted from a healthcare professional interview previously described by AlMahadin et al. 44 The questionnaire for clinicians contains two sections: (1) perspectives of the APP use and (2) recommendations of APP use. Each questionnaire contains three types of measures: (1) multiple choice, (2) five-point Likert scale, and (3) open-ended questions.

    Measured: When the infant 18 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted26 Jul 2024
  2. Study start17 Oct 2024
  3. Primary completion31 Jul 2027 (estimated)
  4. Study completion31 Jul 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
242 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06521918
Sponsor's protocol ID
202311095RIND
Status last verified
Dec 2024
First submitted
21 Jul 2024
Last updated
13 Jan 2025
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of Motor Disorders, run by National Taiwan University Hospital at 1 site in Taiwan.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 13 Jan 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Taiwan. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Suh-Fang Jeng, Professor (886-2-33668132, jeng@ntu.edu.tw), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Alberta Infant Motor Scale (AIMS) (time frame: 3 - 18 months of age). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Jan 2025.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in